Study: Too few with hepatitis C start or stick with treatment
from HealthDay News
A new study suggests that only a quarter of people with hepatitis C are willing to start the standard treatment for the serious viral infection. When interferon injections — the current standard treatment — work, which only happens about 16 percent of the time, the risk of dying drops by 45 percent, the University of Southern California researchers said.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063